Our update on the study start up times in selected countries of Central and Eastern Europe where Cromos Pharma operates (Journal of Clinical Research Best Practices)
We are happy to share with you the most comprehensive update on the study start up times in selected countries of Central and Eastern Europe where our company operates.
As you can see from our article that just came out in the Journal of Clinical Research Best Practices and supplements our recent White Paper with information about Romania and Czech Republic, our region remains very accommodating to clinical research and compares favorably to other geographies. This, combined with lightning-fast recruitment and high data quality makes CEE a very attractive location for trial conduct.
We invite you to explore our countries for your upcoming or ongoing clinical development programs and would be happy to answer any related questions.
